uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Increased Circulating Betatrophin Concentrations in Patients with Type 2 Diabetes
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology.
2014 (English)In: International Journal of Endocrinology, ISSN 1687-8337, E-ISSN 1687-8345, Vol. 2014, 323407- p.Article in journal (Refereed) Published
Abstract [en]

Betatrophin has recently been described as a key hormone to stimulate beta-cell mass expansion in response to insulin resistance and obesity in mice. The finding has generated an interest in the development of antidiabetic drugs with betatrophin as the active component. However, the circulating levels of betatrophin in patients with type 2 diabetes are not well known. Betatrophin concentrations in plasma of 27 type 2 diabetes patients and 18 gender-, age-, and BMI-matched controls were measured. Study participants were characterized with regard to BMI, waist and hip circumference, blood pressure, and fasting plasma blood lipids, creatinine, glucose, HbA1c, and C-peptide. HOMA2 indices were calculated. Betatrophin was 40% higher in patients with type 2 diabetes (893 +/- 80 versus 639 +/- 66 pg/mL). Betatrophin positively correlated with age in the controls and with HbA1c in the type 2 diabetes patients. All study participants were insulin resistant with mean HOMA2B IR in both groups exceeding 2 and HOMA2% S < 50%. Control individuals had impaired fasting glucose concentrations. In this report on betatrophin concentrations in type 2 diabetes and insulin resistance, elevated betatrophin levels were measured in the patients with type 2 diabetes. Future studies are clearly needed to delineate the exact role, if any, of betatrophin in regulating human beta-cell mass.

Place, publisher, year, edition, pages
2014. Vol. 2014, 323407- p.
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:uu:diva-227962DOI: 10.1155/2014/323407ISI: 000336575000001OAI: oai:DiVA.org:uu-227962DiVA: diva2:731920
Available from: 2014-07-02 Created: 2014-07-02 Last updated: 2017-12-05Bibliographically approved

Open Access in DiVA

fulltext(1389 kB)182 downloads
File information
File name FULLTEXT01.pdfFile size 1389 kBChecksum SHA-512
6169cf63332a9da5b8e505409c4d22eb644cdc9f7dfaa4851f65b77095d67f8c5350ee563f90ab5d217cece86e8b2691aaca8cc41928489eb2e51086aa9b4ca5
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records BETA

Espes, DanielMartinell, MatsCarlsson, Per-Ola

Search in DiVA

By author/editor
Espes, DanielMartinell, MatsCarlsson, Per-Ola
By organisation
Department of Medical Cell BiologyFamily Medicine and Preventive Medicine
In the same journal
International Journal of Endocrinology
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar
Total: 182 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 741 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf